Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
Soft tissue sarcomas are a form of rare and heterogeneous neoplasms with high recurrence rate and mortality. Over the past decades, less progress has been achieved. Surgical management with or without adjuvant/neoadjuvant radiotherapy is still the first-line treatment for localized soft tissue sarco...
Saved in:
Main Authors: | Jin Yuan MD, Xiaoyang Li MD, PhD, Shengji Yu MD |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/9bcc089f4fd74fe2bc7610c1056457c1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
by: Antoine Italiano, et al.
Published: (2021) -
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
by: Eve Merry, et al.
Published: (2021) -
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
by: Hongsik Kim MD, et al.
Published: (2021) -
Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study
by: Chao Hou MD, et al.
Published: (2021) -
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
by: Whitney E. Lewis, PharmD, et al.
Published: (2021)